Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005226

President sold 15,000 shares at an average $66.84 ($1,002,547)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-01-22 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2021-01-22 Sale −5,524 $66.23 $365,855 9,476 D
RUBINSTEIN JULIE President 2021-01-22 Sale −9,476 $67.19 $636,692 0 D
Derivatives
RUBINSTEIN JULIE President 2021-01-22 Option exercise · Stock Option (Right to Buy) −15,000 170,000 D
Open-market sales · 15,000 sh · avg $66.84 · $1,002,547
Loading xslF345X03/doc4.xml…